Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 

FTSE subdued on falling oil prices and strong sterling

The FTSE 100 struggled with the double whammy of a strong pound amid positive progress on Brexit negotiations and falling oil prices, putting pressure on index heavyweights BP and Royal Dutch Shell.

Vodafone posts €7.83bn loss; sees annual earnings at midpoint of guidance range

Vodafone Group swung to a large first-half loss after it wrote down the value of its assets and narrowed its full-year earnings guidance to the midpoint of its previous range.

AstraZeneca sells US rights to respiratory tract infection treatment

AstraZeneca said Tuesday it had agreed to sell the US rights to its respiratory tract infection treatment to Swedish Orphan Biovitrum AB for an initial $1.5bn in cash and shares.

BTG upgrades pharmaceuticals sales outlook following strong first half

Healthcare company BTG upgraded its pharmaceuticals sales guidance after reporting on Tuesday that first-half profits rose sharply driven by strong performance from its interventional medicine segment.

Taylor Wimpey sales rates improve in second half

Residential developer Taylor Wimpey said sales rates had grown in the second half, as the UK housing market remained resilient despite economic uncertainty.

Registered users only

The page you wish to access is only available to Registered Users

Registration is FREE and you will have access to a large range of FREE and Premium Services.

If you are already Registered please use the login form to the right.

Are you a Shares subscriber trying to log on?

If you have any problems email


Register now for free